BioFilm are pleased to announce the appointment of Chris Hatton as Business Development Director. Chris has a host of experience having previously worked for RohtoMentholatum and Smith Kline Beecham in a variety of sales, marketing and development roles.
January 2010 Successful developed and manufactured a range of woundcare films for Advanced Woundcare companies.
February 2010 Contract signed with the West of Scotland KTP Centre to work in partnership to develop fast dissolving films containing active pharmaceutical ingredients (APIs). http://www.ktpws.org.uk/
March 2010 Associate member of the Ethical Medicines Industry Group (EMIG) http://www.emig.org.uk/
October 2009 Knowledge Transfer Partnership (KTP) No. 7608 awarded to BioFilm and Strathclyde Institute of Pharmacy and Biomedical Sciences.
December 2009 Commercialisation of cosmetic film for French Cosmetic company for Asia and European markets. The films contain a unique formulation to whiten and reduce pigmentation marks.
Performing the official Opening of BioFilm’s Clean Room manufacturing facility,
Alan Walker, Chairman, BioFilm, Iain Ferguson CBE, CEO Tate & Lyle PLC and Trevor Morgan, CEO, BioFilm
May 2009
Blantyre, 15th May 2009. BioFilm Ltd, Europe’s leading producer of thin film products for use in the neutraceutical, cosmeceutical and consumer healthcare sectors, today officially opens its new 4,000 sq ft, medical and pharmaceutical manufacturing facility at its headquarters at Blantyre, near Glasgow, Scotland.
Representing a significant upfront investment of over £1 million, the new facility (known as a Clean Room) enables fast dissolving film products to be developed which need specialised, highly regulated conditions of manufacture and packaging. It consolidates BioFilm’s position at the leading edge of the growing global soluble and dissolvable thin film technology.
The facility has also been equipped with a state-of-the-art single film sachet production line - the first of its type in Europe - allowing BioFilm’s clients to offer single unit dosage which will meet forthcoming regulatory requirements for the delivery of pharmaceuticals in fast-dissolving film format.
News 
